Company Performance - Celestica's stock closed at $257.64, reflecting a +1.12% increase, outperforming the S&P 500's loss of 0.55% on the same day [1] - Over the past month, Celestica's shares have increased by 32.08%, significantly surpassing the Computer and Technology sector's gain of 9.88% and the S&P 500's gain of 3.64% [1] Earnings Forecast - Celestica is expected to report earnings on October 27, 2025, with projections of $1.45 per share, indicating a year-over-year growth of 39.42% [2] - The consensus estimate for revenue is projected at $3 billion, representing a 19.99% growth compared to the same quarter last year [2] Full Year Estimates - For the full year, earnings are projected at $5.55 per share and revenue at $11.63 billion, reflecting increases of +43.04% and +20.61% respectively from the previous year [3] - Recent adjustments to analyst estimates indicate confidence in Celestica's business performance and profit potential [3] Analyst Ratings - The Zacks Rank system currently rates Celestica as 1 (Strong Buy), which has historically outperformed with an average annual gain of +25% since 1988 [5] - Over the past month, the Zacks Consensus EPS estimate for Celestica has remained stable [5] Valuation Metrics - Celestica is trading with a Forward P/E ratio of 45.91, which is a premium compared to its industry's Forward P/E of 20.71 [6] - The Electronics - Manufacturing Services industry, part of the Computer and Technology sector, holds a Zacks Industry Rank of 50, placing it in the top 21% of over 250 industries [6]

Core Viewpoint - Eli Lilly is expected to report significant earnings growth in the upcoming earnings release, with a projected EPS increase of 444.07% year-over-year and a revenue increase of 40.32% [2]. Company Performance - Eli Lilly's stock closed at $746.98, reflecting a -1.06% change from the previous day, underperforming the S&P 500's loss of 0.55% [1]. - Prior to this trading session, Eli Lilly's shares had gained 8.57%, outperforming the Medical sector's loss of 0.2% and the S&P 500's gain of 3.64% [1]. Earnings Estimates - The upcoming earnings report is anticipated on October 30, 2025, with an expected EPS of $6.42 and quarterly revenue projected at $16.05 billion [2]. - For the annual period, the Zacks Consensus Estimates predict earnings of $23.03 per share and revenue of $61.81 billion, representing increases of +77.29% and +37.22% respectively [3]. Analyst Estimates - Recent modifications to analyst estimates for Eli Lilly indicate a positive outlook, with a 0.21% increase in the Zacks Consensus EPS estimate over the last 30 days [6]. - Eli Lilly currently holds a Zacks Rank of 3 (Hold), reflecting a neutral sentiment among analysts [6]. Valuation Metrics - Eli Lilly is trading at a Forward P/E ratio of 32.78, which is a premium compared to the industry average of 14.65 [7]. - The company has a PEG ratio of 1.06, which is lower than the Large Cap Pharmaceuticals industry's average PEG ratio of 1.53 [7]. Industry Context - The Large Cap Pharmaceuticals industry, part of the Medical sector, holds a Zacks Industry Rank of 63, placing it in the top 26% of over 250 industries [8]. - Strong individual industry groups, as measured by the Zacks Industry Rank, tend to outperform weaker groups by a factor of 2 to 1 [8].

Core Viewpoint - Hims & Hers Health, Inc. is experiencing significant growth in earnings and revenue, with upcoming earnings expected to show substantial year-over-year increases, despite a recent decline in stock price [2][3]. Financial Performance - The stock of Hims & Hers Health, Inc. decreased by 2.95% to $56.00, underperforming the S&P 500's daily loss of 0.55% [1] - Over the past month, the stock has risen by 34.22%, contrasting with a 0.2% loss in the Medical sector and a 3.64% gain in the S&P 500 [1] - The company is projected to report an EPS of $0.09, reflecting a 50% growth compared to the same quarter last year, with anticipated revenue of $581.61 million, indicating a 44.84% increase year-over-year [2] - For the entire fiscal year, earnings are expected to be $0.6 per share and revenue is projected at $2.35 billion, representing increases of 122.22% and 58.91% respectively from the previous year [3] Analyst Sentiment - Recent revisions to analyst forecasts for Hims & Hers Health, Inc. are crucial, as positive estimate revisions indicate analyst optimism regarding the company's business and profitability [4] - The Zacks Rank system, which evaluates estimate changes, currently assigns Hims & Hers Health, Inc. a rank of 3 (Hold), with the consensus EPS estimate remaining unchanged over the past month [6] Valuation Metrics - Hims & Hers Health, Inc. has a Forward P/E ratio of 96.47, which is significantly higher than the industry average Forward P/E of 39.85 [7] - The company has a PEG ratio of 3.9, compared to the Medical Info Systems industry's average PEG ratio of 3.35, indicating a premium valuation relative to growth expectations [8] Industry Context - The Medical Info Systems industry, which includes Hims & Hers Health, Inc., holds a Zacks Industry Rank of 70, placing it in the top 29% of over 250 industries [8][9] - The Zacks Industry Rank suggests that the top 50% rated industries outperform the bottom half by a factor of 2 to 1, highlighting the potential for growth within this sector [9]

Company Performance - Vistra Corp. ended the recent trading session at $204.24, showing a -6.28% change from the previous day's closing price, which lagged behind the S&P 500's daily loss of 0.55% [1] - Over the past month, shares of Vistra Corp. gained 14.65%, while the Utilities sector lost 1.16% and the S&P 500 gained 3.64% [1] Upcoming Earnings - Analysts expect Vistra Corp. to post earnings of $1.97 per share in the upcoming earnings release, representing a year-over-year decline of 62.48% [2] - The consensus estimate predicts revenue to be $7.34 billion, indicating a 16.71% increase compared to the same quarter of the previous year [2] Full Year Projections - For the full year, Zacks Consensus Estimates project earnings of $6.3 per share and revenue of $21.59 billion, reflecting changes of -10% and +25.33% from the prior year, respectively [3] - Recent adjustments to analyst estimates for Vistra Corp. may indicate optimism about the business outlook [3] Valuation Metrics - Vistra Corp. has a Forward P/E ratio of 34.59, which is higher than the industry average Forward P/E of 18.13, suggesting that Vistra Corp. is trading at a premium [6] - The company currently has a PEG ratio of 3.4, compared to the Utility - Electric Power industry's average PEG ratio of 2.7 [7] Industry Ranking - The Utility - Electric Power industry ranks in the top 35% of all industries, with a current Zacks Industry Rank of 86 [8] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [8]

Earnings Performance - Worthington Enterprises reported quarterly earnings of $0.74 per share, missing the Zacks Consensus Estimate of $0.80 per share, but showing an increase from $0.50 per share a year ago, resulting in an earnings surprise of -7.50% [1] - The company posted revenues of $303.71 million for the quarter ended August 2025, which was 2.63% below the Zacks Consensus Estimate and an increase from $257.31 million year-over-year [2] Stock Performance - Worthington Enterprises shares have increased approximately 52.2% since the beginning of the year, significantly outperforming the S&P 500's gain of 13.8% [3] Future Outlook - The current consensus EPS estimate for the upcoming quarter is $0.71 on revenues of $309.4 million, and for the current fiscal year, it is $3.65 on revenues of $1.3 billion [7] - The Zacks Industry Rank indicates that the Building Products - Wood sector is currently in the bottom 7% of over 250 Zacks industries, which may impact the stock's performance [8]

分组1 - MillerKnoll reported quarterly earnings of $0.45 per share, exceeding the Zacks Consensus Estimate of $0.35 per share, and showing an increase from $0.36 per share a year ago, representing an earnings surprise of +28.57% [1] - The company achieved revenues of $955.7 million for the quarter ended August 2025, surpassing the Zacks Consensus Estimate by 4.60%, and an increase from $861.5 million year-over-year [2] - Over the last four quarters, MillerKnoll has surpassed consensus EPS estimates three times and topped consensus revenue estimates three times [2] 分组2 - The stock has underperformed the market, losing about 11.9% since the beginning of the year, while the S&P 500 gained 13.8% [3] - The current consensus EPS estimate for the upcoming quarter is $0.42 on revenues of $970.35 million, and for the current fiscal year, it is $1.81 on revenues of $3.79 billion [7] - The Zacks Industry Rank indicates that the Furniture industry is currently in the bottom 18% of over 250 Zacks industries, suggesting potential challenges for stock performance [8]

Company Performance - Micron reported quarterly earnings of $3.03 per share, exceeding the Zacks Consensus Estimate of $2.86 per share, and showing a significant increase from $1.18 per share a year ago, representing an earnings surprise of +5.94% [1] - The company achieved revenues of $11.32 billion for the quarter ended August 2025, surpassing the Zacks Consensus Estimate by 0.47%, and up from $7.75 billion year-over-year [2] - Over the last four quarters, Micron has consistently surpassed consensus EPS estimates and topped revenue estimates three times [2] Stock Performance - Micron shares have increased approximately 95.6% since the beginning of the year, significantly outperforming the S&P 500's gain of 13.8% [3] - The stock currently holds a Zacks Rank 1 (Strong Buy), indicating expectations for continued outperformance in the near future [6] Future Outlook - The current consensus EPS estimate for the upcoming quarter is $3.05 on revenues of $12.05 billion, while for the current fiscal year, the estimate is $13.25 on revenues of $50.96 billion [7] - The outlook for the industry, particularly the Computer - Integrated Systems sector, is favorable, ranking in the top 6% of over 250 Zacks industries, which historically outperforms the bottom 50% by more than 2 to 1 [8]

Company Performance - AAR reported quarterly earnings of $1.08 per share, exceeding the Zacks Consensus Estimate of $0.98 per share, and up from $0.85 per share a year ago, representing an earnings surprise of +10.20% [1] - The company posted revenues of $739.6 million for the quarter ended August 2025, surpassing the Zacks Consensus Estimate by 7.86%, compared to $661.7 million in the same quarter last year [2] - AAR has surpassed consensus EPS estimates in all four of the last quarters and has topped consensus revenue estimates three times during the same period [2] Stock Performance - AAR shares have increased approximately 25.5% since the beginning of the year, outperforming the S&P 500's gain of 13.8% [3] - The current consensus EPS estimate for the upcoming quarter is $1.07 on revenues of $706.94 million, and for the current fiscal year, it is $4.43 on revenues of $2.87 billion [7] Industry Outlook - The Aerospace - Defense Equipment industry, to which AAR belongs, is currently ranked in the top 25% of over 250 Zacks industries, indicating a favorable outlook [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact AAR's stock performance [5]

Key Takeaways NVIDIA and OpenAI recently announced a collaboration. NVIDIA has announced many other deals in 2025 so far. Shares still reflect prime exposure for the AI frenzy. The AI frenzy continues to dominate headlines, with poster-child NVIDIA (NVDA) at the forefront yet again.But why?NVIDIA unveiled a strategic partnership to deploy at least 10 gigawatts of NVIDIA systems for OpenAI’s next-generation AI infrastructure to train and run its next generation of models.And to support the deployment, NVIDIA ...

Company Overview - Xperi (XPER) shares increased by 6.6% to close at $6.51, supported by higher trading volume compared to normal sessions, contrasting with a 1.6% loss over the past four weeks [1] - The company is making progress on key growth initiatives, including enhanced engagement on its TV platform, expansion in connected vehicles, and continued adoption of IPTV [1] Earnings Expectations - Xperi is expected to report quarterly earnings of $0.25 per share, reflecting a year-over-year decline of 51%, with revenues projected at $110.5 million, down 16.9% from the same quarter last year [2] - The consensus EPS estimate for Xperi has remained unchanged over the last 30 days, indicating that stock price movements may not sustain without trends in earnings estimate revisions [3] Industry Context - Xperi holds a Zacks Rank of 1 (Strong Buy) within the Technology Services industry, indicating strong market sentiment [4] - Another company in the same industry, NextNav Inc. (NN), saw a 0.6% increase in its stock price, closing at $17.18, with a 9.9% return over the past month [4]